Clene Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Clene Inc. (CLNN) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$8.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-14
- Clene Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$8.00K, a 112.70% decline year-over-year.
- Clene Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was $44.00K, a 193.33% increase year-over-year.
- Clene Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $22.00K.
- Clene Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $1.00K, a 98.11% decline year-over-year.
- Clene Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $101.00K.
- Clene Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$128.00K.
- Clene Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was -$4.00K.
- Clene Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$30.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$8.00K 10-Q · filed 2026-08-14 | $36.00K 10-Q · filed 2026-08-14 | $58.00K derived: sum of 3 quarters · filed 2026-08-14 | $59.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $44.00K 10-Q · filed 2026-05-14 | $66.00K derived: sum of 2 quarters · filed 2026-05-14 | $67.00K derived: sum of 3 quarters · filed 2026-05-14 | $130.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $23.00K derived: sum of 2 quarters · filed 2026-03-17 | $86.00K derived: sum of 3 quarters · filed 2026-08-14 | $101.00K 10-K · filed 2026-03-17 |
| 2025-09-30 | $1.00K 10-Q · filed 2025-11-13 | $64.00K derived: sum of 2 quarters · filed 2026-08-14 | $79.00K 10-Q · filed 2025-11-13 | -$73.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $63.00K 10-Q · filed 2026-08-14 | $78.00K 10-Q · filed 2026-08-14 | -$74.00K derived: sum of 3 quarters · filed 2026-08-14 | -$21.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $15.00K 10-Q · filed 2026-05-14 | -$137.00K derived: sum of 2 quarters · filed 2026-05-14 | -$84.00K derived: sum of 3 quarters · filed 2026-05-14 | -$54.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$152.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$99.00K derived: sum of 2 quarters · filed 2026-03-17 | -$69.00K derived: sum of 3 quarters · filed 2026-03-17 | -$128.00K 10-K · filed 2026-03-17 |
| 2024-09-30 | $53.00K 10-Q · filed 2025-11-13 | $83.00K derived: sum of 2 quarters · filed 2025-11-13 | $24.00K 10-Q · filed 2025-11-13 | $134.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $30.00K 10-Q · filed 2025-08-14 | -$29.00K 10-Q · filed 2025-08-14 | $81.00K derived: sum of 3 quarters · filed 2025-08-14 | -$4.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$59.00K 10-Q · filed 2025-05-07 | $51.00K derived: sum of 2 quarters · filed 2025-05-07 | -$34.00K derived: sum of 3 quarters · filed 2025-05-07 | -$81.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $25.00K derived: sum of 2 quarters · filed 2025-03-24 | -$22.00K derived: sum of 3 quarters · filed 2025-03-24 | -$4.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | -$85.00K 10-Q · filed 2024-11-13 | -$132.00K derived: sum of 2 quarters · filed 2024-11-13 | -$114.00K 10-Q · filed 2024-11-13 | $9.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$47.00K 10-Q · filed 2024-08-07 | -$29.00K 10-Q · filed 2024-08-07 | $94.00K derived: sum of 3 quarters · filed 2024-08-07 | $88.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $18.00K 10-Q · filed 2024-05-08 | $141.00K derived: sum of 2 quarters · filed 2024-05-08 | $135.00K derived: sum of 3 quarters · filed 2024-05-08 | -$12.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $117.00K derived: sum of 2 quarters · filed 2024-03-13 | -$30.00K derived: sum of 3 quarters · filed 2024-03-13 | -$30.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | -$6.00K 10-Q · filed 2023-11-07 | -$153.00K derived: sum of 2 quarters · filed 2023-11-07 | -$153.00K 10-Q · filed 2023-11-07 | |
| 2022-06-30 | -$147.00K 10-Q · filed 2023-08-14 | -$147.00K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | -$92.00K 10-K · filed 2023-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |